Adis Journals
Browse
- No file added yet -

Real-world Comparative Effectiveness of Canagliflozin Versus Empagliflozin and Dapagliflozin in Patients with Type 2 Diabetes in the United States

Download (108.7 kB)
figure
posted on 2020-11-02, 11:53 authored by Lawrence Blonde, Charmi Patel, Bingcao Wu, Yen-Wen Chen, Christopher D. Pericone, Brahim Bookhart

Article full text


The above Summary Slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.

History

Usage metrics

    Advances in Therapy

    Categories

    Keywords

    CanagliflozinDapagliflozinEmpagliflozinGlycated hemoglobinGlycemic efficacyType 2 diabetes mellitus

    Licence

    CC BY-NC 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC